Postbiotics vs. Fish Oil for Dog Inflammation: Which One Actually Earns Its Spot in the Bowl

By Koranda Walsh, VMD, DACVIM (SAIM), DACVP (CP)

✓ Medically reviewed by Koranda Walsh, VMD, DACVIM (SAIM), DACVP (CP) — August 6, 2026 For general education — not a substitute for veterinary care.

Comparisons · August 17, 2026 · 5 min read

Fish oil has the repeated, dosed, force-plate data for joint inflammation; postbiotics have real gut-barrier evidence but not that.

A twelve-year-old Labrador named Otis came into my exam room three winters ago because his owner said he’d “gotten slow on stairs since October.” Same dog, same house, same food — the only new variable was the season and a stiffening left hip. I asked what she’d already tried. She’d started him on a gut-health chew with postbiotics because a friend swore by it for her own dog’s loose stools. Otis didn’t have loose stools. He had osteoarthritis. The chew wasn’t wrong, exactly — it just wasn’t aimed at the joint he was limping on.

That’s the mix-up I see constantly, and it’s the whole reason this comparison exists. Postbiotics and fish oil both get marketed under the umbrella word “inflammation,” and pet owners reasonably assume that means they’re interchangeable. They are not. They work on different tissue, through different mechanisms, and the research behind each one lives in a different part of the literature. If you read the label and the bloodwork before you read the claim — which is how I’d urge any owner to shop — the difference gets obvious fast.

What “inflammation” actually means on two different labels

Fish oil’s anti-inflammatory case is built on omega-3 fatty acids — EPA and DHA — competing with arachidonic acid in cell membranes and shifting the eicosanoid pathway toward less inflammatory signaling molecules. That’s biochemistry with decades of human and veterinary study behind it, and in dogs it has been tested specifically against joint disease. A PubMed: multicenter veterinary practice assessment of omega-3 fatty acid supplementation in dogs with osteoarthritis found measurable improvement in owner- and vet-assessed lameness scores across general practice settings, not just a university lab. And a more mechanistic trial using force-plate gait analysis — the closest thing veterinary orthopedics has to an objective ruler — found in the Journal of the American Veterinary Medical Association that dogs fed a fish-oil-enriched diet showed a significant improvement in peak vertical force on the affected limb by day 90, versus no significant change in the control group. That’s a joint getting measurably more weight put through it, not just an owner’s impression.

Postbiotics work on a completely different axis. They’re the metabolic byproducts of probiotic fermentation — short-chain fatty acids, cell wall fragments, other nonliving compounds — and their anti-inflammatory story is about the gut lining, not the joint capsule. A Veterinary Sciences study of a novel prebiotic-and-postbiotic supplement in healthy dogs documented shifts in gut microbiota composition alongside changes in intestinal barrier markers, consistent with reduced local gut inflammation. That’s real, replicable evidence — for the gut. I have not seen a postbiotic trial in dogs that used force plates, goniometry, or any orthopedic outcome measure at all, because that isn’t the tissue postbiotics are being tested on.

Reading the guaranteed analysis instead of the marketing copy

This is the part I actually care about as a clinical pathologist: what does the label tell you the dog is getting, and does that dose match anything in a published trial? For fish oil, Today’s Veterinary Practice lays out that dosing should be based on combined EPA+DHA content, not total fish oil weight, and that the National Research Council’s safe upper limit sits around 280 mg EPA+DHA per 100 kcal of diet. If a bag or bottle doesn’t break out EPA and DHA separately from “total omega-3s” or “fish oil,” you can’t actually compare it to the trial doses that produced the joint benefit — you’re guessing. NASC certification on the label is a decent proxy for manufacturing quality and adverse-event tracking, but it says nothing about whether the dose inside matches what was studied.

Postbiotic labels have a parallel problem, just earlier in its life cycle: strain and compound identification is inconsistent across brands, and “postbiotic” as a category term covers everything from purified short-chain fatty acids to whole fermented yeast cell walls, which are not biologically interchangeable. If the label doesn’t name what the postbiotic actually is — not just the word “postbiotic” — you have no way to connect it to any specific study, including the gut-barrier one above.

The stairs conversation I have most weeks

I’ve watched this exact conflict play out with an eight-year-old spayed female mixed breed, about 55 pounds, whose owner had spent four months giving a postbiotic gut supplement for what she described as “general wellness and maybe some inflammation,” while the dog’s actual complaint — first noticed after a long hike in early fall — was reluctance to jump onto the tailgate of the owner’s truck and a hitch in her gait after resting on the living room floor. Nothing about the dog’s stool, appetite, or GI history suggested a gut problem. When I re-examined her, she had bilateral stifle discomfort on palpation and mild crepitus. We switched the supplement budget toward a dosed fish oil product and added a joint-support conversation with her regular vet. Within six weeks the owner reported the dog was jumping onto the tailgate again without hesitation. I want to be precise about what that case is and isn’t: it’s one dog, one owner’s observation, not a trial, and I’m not presenting it as a success rate. But it’s a clean illustration of matching the supplement to the organ system, which is the entire argument of this article.

Where postbiotics genuinely win

None of this makes postbiotics a lesser supplement — it makes them a different one. If a dog’s presenting problem is loose stool, food sensitivity flares, or general digestive inflammation, postbiotics have the more directly relevant evidence, and fish oil isn’t positioned to address a leaky gut lining the way a barrier-support postbiotic is. Our guide on prescription veterinary probiotics vs. over-the-counter dog probiotics goes further into how to evaluate that category on its own terms, strain by strain. And if joint pain is the actual complaint but a dog can’t tolerate fish oil’s calorie load or has a history of pancreatitis, it’s worth reading how fish oil stacks up against a different joint-support option in our fish oil vs. glucosamine comparison before assuming fish oil is the only lane.

The bottom line, in plain terms

If the complaint is a joint — stiffness after rest, hesitation on stairs, a limp that comes and goes — fish oil is the supplement with the dosed, repeated, force-plate-verified data behind it, and the label should show you EPA and DHA numbers you can compare to published trials. If the complaint is the gut — stool quality, food reactivity, barrier integrity — postbiotics have their own, separate evidence base, and that’s where they belong. Anyone shopping either category should also check how the product’s own listed audience overlaps: brands like La Petite Labs and Zesty Paws sell into adjacent wellness categories, and it’s worth asking what the specific ingredient panel — not the front-of-bag claim — actually supports. I still open every bag the same way: turn it over, find the guaranteed analysis, and see whether the dose on the label matches a dose that was ever actually tested.